JP2020521447A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521447A5 JP2020521447A5 JP2019564782A JP2019564782A JP2020521447A5 JP 2020521447 A5 JP2020521447 A5 JP 2020521447A5 JP 2019564782 A JP2019564782 A JP 2019564782A JP 2019564782 A JP2019564782 A JP 2019564782A JP 2020521447 A5 JP2020521447 A5 JP 2020521447A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024109160A JP2024133640A (ja) | 2017-05-25 | 2024-07-05 | 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511010P | 2017-05-25 | 2017-05-25 | |
| US62/511,010 | 2017-05-25 | ||
| PCT/US2018/034655 WO2018218151A1 (en) | 2017-05-25 | 2018-05-25 | Novel oncolytic viruses for sensitizing tumor cells to killing by natural killer cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109160A Division JP2024133640A (ja) | 2017-05-25 | 2024-07-05 | 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521447A JP2020521447A (ja) | 2020-07-27 |
| JP2020521447A5 true JP2020521447A5 (https=) | 2021-07-26 |
| JP7522426B2 JP7522426B2 (ja) | 2024-07-25 |
Family
ID=64397136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019564782A Active JP7522426B2 (ja) | 2017-05-25 | 2018-05-25 | 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス |
| JP2024109160A Pending JP2024133640A (ja) | 2017-05-25 | 2024-07-05 | 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024109160A Pending JP2024133640A (ja) | 2017-05-25 | 2024-07-05 | 天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11684637B2 (https=) |
| EP (1) | EP3630144A4 (https=) |
| JP (2) | JP7522426B2 (https=) |
| KR (2) | KR102700175B1 (https=) |
| CN (1) | CN110891584B (https=) |
| AU (1) | AU2018273963B2 (https=) |
| BR (1) | BR112019024656A2 (https=) |
| CA (1) | CA3064897A1 (https=) |
| IL (1) | IL270876B2 (https=) |
| WO (1) | WO2018218151A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190256A1 (ar) | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
| WO2019032628A1 (en) | 2017-08-07 | 2019-02-14 | The Regents Of The University Of California | GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS |
| WO2020037215A1 (en) | 2018-08-17 | 2020-02-20 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease |
| WO2020154640A1 (en) * | 2019-01-24 | 2020-07-30 | University Of Central Florida Research Foundation, Inc. | Compositions and methods for stimulating natural killer cells |
| US20230330140A1 (en) * | 2019-11-25 | 2023-10-19 | Ansun Biopharma, Inc. | Immune cell delivery of sialidase cancer cells, immune cells and the tumor microenvironment |
| CN111676245B (zh) * | 2020-06-24 | 2022-09-13 | 武汉波睿达生物科技有限公司 | 一种含有HSV-1型溶瘤病毒的NFAT-Cre-CAR-T细胞及其应用 |
| KR20230048046A (ko) * | 2020-08-12 | 2023-04-10 | 유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 | 감마 델타 t 세포를 자극하기 위한 방법 및 조성물 |
| CN112852757A (zh) * | 2021-02-01 | 2021-05-28 | 南京大学 | 一种制备新型溶瘤病毒EM/VSV-G Ad5sPVRCD137L的方法 |
| CA3215085A1 (en) * | 2021-04-08 | 2022-10-13 | Immvira Biopharmaceuticals Co., Limited | Genetically modified oncolytic herpes simplex virus delivering chemokine and tumor associated/specific antigen |
| CN115678854A (zh) * | 2021-07-29 | 2023-02-03 | 上海中医药大学 | 一种基因工程细胞及其制备方法和应用 |
| CN116875547A (zh) * | 2023-09-04 | 2023-10-13 | 山东德升细胞治疗工程技术有限公司 | 一种利用细胞外泌体激活nk细胞的体外扩增培养方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (https=) | 1968-10-17 | 1970-08-24 | ||
| US20020187543A1 (en) * | 2001-04-05 | 2002-12-12 | Curiel David T. | Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins |
| US20090214590A1 (en) * | 2005-07-08 | 2009-08-27 | Wayne State University | Virus Vaccines Comprising Envelope-Bound Immunomodulatory Proteins and Methods of Use Thereof |
| US20080299137A1 (en) | 2005-10-28 | 2008-12-04 | Novo Nordisk A/S | Fusion Proteins That Bind Effector Lymphocytes And Target Cells |
| WO2008067305A2 (en) | 2006-11-28 | 2008-06-05 | Giic Research Development Corporation | Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain |
| US8652466B2 (en) * | 2006-12-08 | 2014-02-18 | Macrogenics, Inc. | Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting |
| US20100178684A1 (en) | 2006-12-21 | 2010-07-15 | Woo Savio L C | Transgenic oncolytic viruses and uses thereof |
| FR2938840B1 (fr) * | 2008-11-21 | 2010-12-17 | Centre Nat Rech Scient | Proteines mutantes de la proteine f de piv-5 et de piv-2 |
| AU2009332883B2 (en) | 2008-12-22 | 2015-05-21 | Oncos Therapeutics Oy | Oncolytic adenoviral vectors and methods and uses related thereto |
| US9592287B2 (en) * | 2009-10-09 | 2017-03-14 | New York Blood Center, Inc. | Immunopotentiator-linked oligomeric influenza immunogenic compositions |
| ES2728248T3 (es) * | 2012-01-24 | 2019-10-23 | Univ Georgia | Vacunas basadas en el virus paragripal 5 |
| LT3578201T (lt) * | 2012-06-28 | 2023-05-25 | University Of Central Florida Research Foundation Incorporated | Nk ląstelių metodai ir kompozicijos |
| WO2014037124A1 (en) * | 2012-09-04 | 2014-03-13 | Bavarian Nordic A/S | Methods and compositions for enhancing vaccine immune responses |
| WO2014041119A1 (en) * | 2012-09-14 | 2014-03-20 | Deutsches Krebsforschungszentrum | Oncolytic viruses expressing immuno-nucleases |
| EP2968525A4 (en) | 2013-03-14 | 2016-10-26 | Icahn School Med Mount Sinai | MORBUS NEWCASTLE VIRUSES AND USES THEREOF |
| WO2015069745A2 (en) * | 2013-11-05 | 2015-05-14 | The Board Of Regents Of The University Of Texas System | Tumors expressing igg1 fc induce robust cd8 cell responses |
| US10238700B2 (en) * | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| JP2017530114A (ja) | 2014-09-26 | 2017-10-12 | バヴァリアン・ノルディック・アクティーゼルスカブ | フラジェリンをコードする組み換えｍｖａによる鼻腔内免疫のための方法と組成物 |
| HK1245080A1 (zh) * | 2014-10-27 | 2018-08-24 | University Of Central Florida Research Foundation, Inc. | 自然杀伤细胞的方法和组合物 |
| JP6797803B2 (ja) * | 2014-12-31 | 2020-12-09 | セルジーン コーポレイション | ナチュラルキラー細胞を用いて血液障害、固形腫瘍、又は感染性疾患を治療する方法 |
| JP6961490B2 (ja) | 2015-04-08 | 2021-11-05 | ノバルティス アーゲー | Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法 |
| HRP20200439T1 (hr) * | 2015-04-30 | 2020-06-12 | Psioxus Therapeutics Limited | Onkolitički adenovirus koji kodira protein b7 |
| WO2018083259A1 (en) | 2016-11-03 | 2018-05-11 | Psioxus Therapeutics Limited | Oncolytic adenovirus encoding transgenes |
-
2018
- 2018-05-25 EP EP18806947.0A patent/EP3630144A4/en active Pending
- 2018-05-25 BR BR112019024656A patent/BR112019024656A2/pt unknown
- 2018-05-25 JP JP2019564782A patent/JP7522426B2/ja active Active
- 2018-05-25 KR KR1020197037594A patent/KR102700175B1/ko active Active
- 2018-05-25 WO PCT/US2018/034655 patent/WO2018218151A1/en not_active Ceased
- 2018-05-25 AU AU2018273963A patent/AU2018273963B2/en active Active
- 2018-05-25 CN CN201880047292.0A patent/CN110891584B/zh active Active
- 2018-05-25 KR KR1020247028510A patent/KR20240132124A/ko active Pending
- 2018-05-25 CA CA3064897A patent/CA3064897A1/en active Pending
- 2018-05-25 US US16/616,671 patent/US11684637B2/en active Active
- 2018-05-25 IL IL270876A patent/IL270876B2/en unknown
-
2023
- 2023-05-15 US US18/317,616 patent/US12312393B2/en active Active
-
2024
- 2024-07-05 JP JP2024109160A patent/JP2024133640A/ja active Pending